On Friday shares of Peabody Energy Corp. (NYSE:BTU) closed at $6.14. Company’s sales growth for last 5 years was 3.00% and EPS growth for next 5 years is recorded as 12.08%. On March 16, Peabody Energy Corp. (NYSE:BTU) announced that the early tender period for the previously announced tender offer to purchase for cash any and all of the $650 million aggregate principal amount outstanding of its 7 3/8% Senior Notes due 2016 expired at 5:00 p.m., New York City time, on March 13, 2015.
Delta Air Lines, Inc. (NYSE:DAL) in last trading activity moved up 0.34% to close at $47.42. Company weekly performance is 4.22% while its quarterly performance stands at 2.91%. Delta Air Lines, Inc. (NYSE:DAL) is -6.94% away from its 52 week high. On March 18, Delta Air Lines (NYSE:DAL) said carriers based in the Persian Gulf are receiving subsidies worth tens of billions of dollars from the governments of the U.A.E. and Qatar, as the war of words between airlines in the U.S. and the Middle East continue.
On last trading day Dynatronics Corp. (NASDAQ:DYNT) decreased -0.36% to close at $2.92. Its volatility for the week is 2.63% while volatility for the month is 2.74%. DYNT’s sales growth for past 5 years was -3.30% and its EPS growth for past 5 years was -36.60%. Dynatronics Corp. (NASDAQ:DYNT) monthly performance is -17.78%.
Barracuda Networks, Inc. (NYSE:CUDA) has 17.50% insider ownership while its institutional ownership stands at 54.40%. In last trading activity company’s stock closed at $38.33. Barracuda Networks, Inc. (NYSE:CUDA has updated its MDM solution, a free cloud-based mobile device and application management service. Barracuda MDM is part of the company’s Total Threat Protection initiative, and now includes support for Android operating systems. With this announcement Barracuda is offering customers more choices to manage various mobility initiatives across a wide range of industries.
On Friday shares of Pfizer Inc. (NYSE:PFE) closed at $34.25. Company’s sales growth for last 5 years was 0.10% and EPS growth for next 5 years is recorded as 2.17%.
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical program for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with the collaboration agreement.